MedTrace Logo

[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin

NCT06644716 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-02-12

No results posted yet for this study

Summary

The investigators will determine the proportion of CUP patients in whom the primary tumor can be identified by \[18F\]F-FAPI PET-CT.

Conditions

  • Cancer of Unknown Primary

Interventions

DIAGNOSTIC_TEST

[18F]F-FAPI PET-CT

Each patient will receive a FAPI PET-CT.

Sponsors & Collaborators

  • Dutch Cancer Society

    collaborator OTHER

  • Academisch Ziekenhuis Maastricht

    collaborator OTHER

  • Missie Tumor Onbekend

    collaborator UNKNOWN

  • Noordwest Ziekenhuisgroep

    collaborator OTHER

  • Cyclotron Noordwest BV

    collaborator UNKNOWN

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Sophie Veldhuijzen van Zanten · Erasmus Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-19
Primary Completion
2026-08-31
Completion
2027-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06644716 on ClinicalTrials.gov